
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MSCL | Toronto | CAD | Real-time | |
MSCLF | OTC Markets | USD | Delayed | |
MSCL | CBOE Canada | CAD | Real-time |
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
John R. Perfect | - | 2018 | Member of Clinical Advisory Board |
David W. Denning | - | 2018 | Member of Clinical Advisory Board |
Coleman Rotstein | - | 2010 | Member of Scientific Advisory Board |
Jack D. Sobel | - | 2010 | Member of Scientific Advisory Board |
Philip J. Rosenfeld | - | 2006 | Member of Clinical Advisory Board |
Thomas J. Walsh | - | 2010 | Member of Scientific Advisory Board |
David S. Boyer | - | 2006 | Member of the Clinical Advisory Board |
Andrea Leonardi | - | - | Member of the Clinical Advisory Board |
Michael Liggett | 61 | 2016 | CFO, Corporate Secretary & Director |
Julia G. Levy | 86 | 2005 | Member of the Strategic Advisory Board |
Richard M. Glickman | 63 | 2005 | Member of the Strategic Advisory Board |
Alan Bird | - | 2006 | Member of the Clinical Advisory Board |
Donald N. Buell | - | - | Chairman of the Scientific Advisory Board |
Jason Scott Slakter | 63 | - | Member of Clinical Advisory Board |
William Wasyl Jarosz | 65 | 2006 | Chairman of the Board & CEO |
Peter Hnik | 65 | 2006 | Chief Medical Officer & Director |
Geoff MacKay | 58 | 2018 | Independent Chairman of the Board of Directors |
Francis Gleeson | 69 | 2012 | Co-Founder, CEO, President & Director |
Brian Matthew Bloom | 48 | 2018 | Independent Director |
Perry Shieh | - | 2024 | Member of Clinical Advisory Board |
Francesco Muntoni | - | 2024 | Member of Clinical Advisory Board |
Richard Finkel | - | 2024 | Member of Clinical Advisory Board |
Ronald D. Cohn | - | 2024 | Member of Clinical Advisory Board |
Hanns Lochmuller | - | 2024 | Member of Clinical Advisory Board |
Iris Loew Friedrich | - | 2025 | Independent Director |
Stephanie Brown | 64 | 2024 | Independent Director |
Selwyn Ho | 54 | 2025 | Independent Director |
Nicholas Johnson | - | 2024 | Member of Clinical Advisory Board |
Franklin M. Berger | 76 | 2023 | Independent Director |
Jordan S. Dubow | 47 | 2024 | Chair of Clinical Advisory Board |
Adam S. Mostafa | 45 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review